Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Cilostazol in Promoting Hematoma Clearance After Intracerebral Hemorrhage
NCT06504576Phase 2Recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- Jun 2025
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cilostazol in intracerebral hemorrhage (ICH), sponsored by National Taiwan University Hospital. Started Jun 2025; status: recruiting.
02
Drugs
cilostazol
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT06504576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06504576.